Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-08-18

Clinical Trial Update: Immune Restoration by Lipoic Acid in AIDS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether alpha-lipoic acid can restore immune function in AIDS patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infections | Phase 2 | Status: COMPLETED